Cargando…
Hydroxycarbamide effects on DNA methylation and gene expression in myeloproliferative neoplasms
Hydroxycarbamide (HC, hydroxyurea) is a cytoreductive drug inducing cell cycle blockade. However, emerging evidence suggests that HC plays a role in the modulation of transcription through the activity of transcription factors and DNA methylation. Examining the global mechanism of action of HC in th...
Autores principales: | Contreras Castillo, Stephania, Montibus, Bertille, Rocha, Azucena, Duke, Will, von Meyenn, Ferdinand, McLornan, Donal, Harrison, Claire, Mullally, Ann, Schulz, Reiner, Oakey, Rebecca J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327916/ https://www.ncbi.nlm.nih.gov/pubmed/34244229 http://dx.doi.org/10.1101/gr.270066.120 |
Ejemplares similares
-
Bone marrow niche dysregulation in myeloproliferative neoplasms
por: Curto-Garcia, Natalia, et al.
Publicado: (2020) -
Combination therapies in Myeloproliferative Neoplasms: why do we need them and how to identify potential winners?
por: McLornan, Donal, et al.
Publicado: (2013) -
Transcription of intragenic CpG islands influences spatiotemporal host gene pre-mRNA processing
por: Amante, Samuele M, et al.
Publicado: (2020) -
JAK2 V617F: A Single Mutation in the Myeloproliferative Group of Disorders
por: McLornan, Donal, et al.
Publicado: (2006) -
COVID-19 and myeloproliferative neoplasms: some considerations
por: Kamaz, Baransel, et al.
Publicado: (2020)